Boosting your product pipeline through innovative licensing. Pinpointing and managing successful alliances to remain competitive.
With the recent outbreak of large mergers and acquisitions and the looming pipeline crisis among large pharmaceutical companies, this meeting aimed to bring together senior officers from the business development and licensing sectors of top biotech and pharma companies, to discuss all aspects of licensing with a focus on remaining competitive. Along with in-depth analyses and theories delivered by representatives from investment banks, consultancy firms and academia, the conference presented delegates with interesting viewpoints and practical advice on partnering strategies, and issues surrounding licensing.